Maia Wealth’s Pyxis Oncology PYXS Stock Holding History

Maia Wealth’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-118,900	Closed	-$12	–	333
2025 Q1	$12	Hold	118,900	–	–	﹤0.01%	292
2024 Q4	$951	Buy	+118,900	New	+$343K	﹤0.01%	324

Other funds holding PYXS

GGI

GordonMD Global Investments Beverely Hills, California $207M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maia Wealth's PYXS Position: Q2 2026 in Review

Maia Wealth sold out of Pyxis Oncology (PYXS) in Q2 2026, closing a stake of 21,277 shares — an estimated $31.1K sold.

Maia Wealth first reported a position in PYXS in Q4 2025 and held it in 2 quarters. The position peaked at $31.1K in Q1 2026. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

Maia Wealth reported no remaining Pyxis Oncology position as of Q2 2026 after selling out during the quarter.
Maia Wealth sold 21,277 Pyxis Oncology shares in Q2 2026, an estimated $31.1K.
Maia Wealth first reported a position in Pyxis Oncology in Q4 2025 and held it in 2 quarters.
Maia Wealth's Pyxis Oncology position peaked at $31.1K in Q1 2026.
76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Maia Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.